Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
Do you treat early stage breast cancer patients with hypofractionation in the prone position?
Answer from: Radiation Oncologist at Community Practice
Yes as there is no reason not to do it
Sign in or Register to read more
Answer from: Radiation Oncologist at Academic Institution
Yes, there is data to go this, such as:https://www.ncbi.nlm.nih.gov/pubmed/24867535Prone breast set up can be tricky and less reproducible, and thus more rigorous IGRT should be considered
Sign in or Register to read more
3415
3427
Related Questions
Is 5fx APBI and no endocrine therapy a new standard of care for women over 70 years old with low-risk breast cancer given the interim analysis of the EUROPA trial?
In patients with history of prior axillary surgery, subsequently with breast cancer recurrence, and sentinel lymph nodes mapped to internal mammary area (but were not biopsied), do you offer post-mastectomy radiation to cover the IMNs?
What are your top takeaways in Breast Cancer from ESMO 2024?
How do you manage symptomatic fat necrosis following adjuvant breast radiotherapy?
Do you recommend adjuvant RT to patients with non-ATM genetic mutations (e.g. BRCA, NF) who elect to have lumpectomy and are otherwise PRIME II/CALGB candidates for RT omission (i.e. low risk disease characteristics: strongly ER+, <1cm, grade 1-2, no LVI, widely negative margins, and committed to endocrine therapy)?
Given the final publication of NSABP B-51, for which patients meeting trial eligibility would you still recommend regional nodal irradiation?
Would you offer partial breast radiation to a young breast cancer patient with BRCA 1 if all other criteria are met?
What are your top takeaways in Breast Cancer from ASTRO 2024?
With the presentation of HypoG-01 phase III UNICANCER trial at ESMO 2024, should hypofractionated radiotherapy be the standard across the board for breast cancer?
Is stage I B/L breast, ER+ cancer a contraindication to breast radiation omission after breast conservation surgery?